Healthcare -
Biotechnology - NASDAQ - US
$ 4.465
-1.22 %
$ 399 M
Market Cap
-10.15
P/E
TRVI - OTHER FINANCING ACTIVITIES
Other Financing Activities TRVI - Trevi Therapeutics, Inc.
-211 K
LAST VALUE
28.09%
2 YEAR CAGR
-0.42%
5 YEAR CAGR
0.00%
10 YEAR CAGR